Skip to content

Precigen PGEN Intangibles (Net)

Intangibles (Net) at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$6.01M-22.0%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$174M-1.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$27.36M-1.6%
Amgen logo
AmgenAMGN
$20.67B-16.2%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's intangibles (net)?
Precigen (PGEN) reported intangibles (net) of $2.86M in Q1 2026.
How has Precigen's intangibles (net) changed year-over-year?
Precigen's intangibles (net) decreased by 30.8% year-over-year, from $4.14M to $2.86M.
What is the long-term trend for Precigen's intangibles (net)?
Over 5 years (2020 to 2025), Precigen's intangibles (net) has grown at a -45.4% compound annual growth rate (CAGR), from $65.4M to $3.18M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.